pentadecapeptide is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-03-05. Where a claim depends on a specific study, the study is described rather than over-claimed.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C62H98N16O22 | computed for the free peptide |
| Molecular weight | about 1419 Da | monoisotopic mass near 1418.7 |
| Amino acid count | 15 | single chain, no disulfide bonds |
| Solubility | freely soluble in water | also dissolves in saline and phosphate buffer |
| Common synonyms | pentadecapeptide BPC, BPC 157 | fragment notation varies by source |
BPC-157 is a synthetic peptide built from fifteen amino acids, referred to in the literature as a pentadecapeptide. Its sequence was derived from a larger protein found in human gastric juice, commonly called body protection compound. Researchers first described the fragment in the early 1990s and named it after the parent protein plus a numeric identifier. The peptide does not correspond to a single marketed medicine; it is primarily a laboratory research material. Suppliers distribute it as a lyophilized powder intended for experimental use.
Published work on BPC-157 spans several decades and covers a wide range of experimental models. Much of the early literature reports outcomes in animal studies involving induced injury to the gastrointestinal tract, tendons, and other tissues. The volume of preclinical reports is large, while controlled human trials remain scarce. This imbalance is a recurring point of discussion, because animal findings do not automatically translate into human effects. Reviews often note that study designs differ substantially across laboratories.
Lyophilized material is generally reported as stable for extended periods when kept cold, dry, and protected from light. In solution, the main degradation routes for a peptide of this type are hydrolysis of peptide bonds and aggregation. The sequence contains no cysteine, so disulfide-driven oxidation is not a primary concern, though methionine and tryptophan are also absent. Stability depends on pH, buffer composition, and concentration, with acidic conditions often reported as more favorable than neutral or alkaline ones. Repeated freeze-thaw cycles can promote aggregation, and how fast degradation proceeds at room temperature in specific formulations remains an open question.
Handling practice centers on limiting moisture, heat, and mechanical stress. Powder is typically allowed to reach room temperature before opening so that condensation does not form on the contents, and solutions are prepared with sterile or low-particulate water. Peptides can adsorb to certain plastics and membrane filters, so container and filter material is sometimes specified to reduce losses at low concentrations. Working aliquots are usually frozen separately rather than sampled repeatedly from one stock. Recording lot number, preparation date, and storage conditions supports later comparison between experiments.
Identity and purity are usually assessed by reversed-phase high-performance liquid chromatography, which separates the target peptide from truncated sequences and other synthesis by-products. Mass spectrometry, typically electrospray ionization coupled to liquid chromatography, confirms the expected mass and helps detect modifications. Amino acid analysis can verify composition when residue-level confirmation is needed. Because common impurities differ from the target by only one or two residues, chromatographic resolution often matters more than a single headline purity percentage. Impurity profiles are most informative when compared against a validated reference standard.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
Confirmation of identity and purity relies on standard peptide analysis techniques. Reverse-phase high-performance liquid chromatography separates the peptide from related impurities and serves as the most common purity assay. Mass spectrometry, often coupled to that chromatography step, provides an accurate molecular mass that can be matched against the expected value. Amino acid analysis or sequencing can be added for further confirmation. Because short peptides can be produced by different synthetic routes, laboratories usually report both a chromatographic purity percentage and a mass confirmation rather than a single figure.
Due to the neurotoxicity of its metabolite, norpethidine, it is more toxic than other opioids—especially during long-term use. The norpethidine metabolite was found to have serotonergic effects, so pethidine could, unlike most opioids, increase the risk of triggering serotonin syndrome.
Typically, chia seeds are small flattened ovoids measuring on average 2.1 mm × 1.3 mm × 0.8 mm (0.08 in × 0.05 in × 0.03 in), with an average weight of 1.3 mg per seed. They are mottle-colored with brown, gray, black, and white. The seeds are hygroscopic, absorbing up to 12 times their weight in liquid when soaked; they develop a mucilaginous coating that gives them a gel texture. Chia (or chian or chien) has mostly been identified as Salvia hispanica L. Other plants referred to as "chia" include "golden chia" (Salvia columbariae). The seeds of Salvia columbariae are also used for food.
=== Prophecy === In Tales of the Green Lantern Corps Annual #2 (1986), a prophecy narrated to Abin Sur suggests that Mogo will be the last Green Lantern. In a battle with the "Empire of Tears", Ranx the Sentient City will explode a bomb in Mogo's core, killing him and ending the Green Lantern Corps. The Sinestro Corps attack Mogo with Ranx, who started to drill into the planet, with the intention of planting the blink bomb. It was revealed that Mogo is the one who guides the rings of deceased Lanterns to find new replacements and that if he should die, the Corps would be unable to recruit members in this manner. Thanks to the efforts of Sodam Yat, as well as a change in the Book of Oa permitting the Lanterns to use lethal force against the Sinestro Corps, Ranx is destroyed and the Sinestro Corps are driven from Mogo.
== Further reading == Krentz, Benjamin D.; Mulheron, Heidi J.; Semrau, Jeremy D.; DiSpirito, Alan A.; Bandow, Nathan L.; Haft, Daniel H.; Vuilleumier, Stéphane; Murrell, J. Colin; McEllistrem, Marcus T.; Hartsel, Scott C.; Gallagher, Warren H. (30 November 2010). "A Comparison of Methanobactins from Methylosinus trichosporium OB3b and Methylocystis Strain SB2 Predicts Methanobactins Are Synthesized from Diverse Peptide Precursors Modified To Create a Common Core for Binding and Reducing Copper Ions". Biochemistry. 49 (47): 10117–10130. doi:10.1021/bi1014375. PMC 3924600. PMID 20961038. Dalton, edited by J. Colin Murrell, Howard (1992). Methane and Methanol Utilizers. Boston, MA: Springer US. ISBN 1-4899-2338-1. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link) Gribble, volume editor, Gordon W. (2003). Natural production of organohalogen compounds. Berlin: Springer. ISBN 3-540-45293-1. {{cite book}}: |first1= has generic name (help)CS1 maint: multiple names: authors list (link)
Sources: en.wikipedia.org
== Phylogenetic Domain Comparison == Eukaryotes usually have two separate enzymes, while most prokaryotes have a single bifunctional protein that can carry out both catalyses, although exceptions occur in both cases. While eukaryotic monofunctional RFK is orthologous to the bifunctional prokaryotic RFK module, the monofunctional FMNAT differs from its prokaryotic counterpart, and is instead related to the PAPS-reductase family. The bacterial FMNAT module of the bifunctional enzyme has remote similarity to eukaryotic nucleotidyltransferases and, hence, it may be involved in the adenylylation reaction of FAD synthetases.
The Economic Times cited surveys showing "broad negative sentiment" about the economy, and Harris being "relentlessly hammered" by Trump during campaigns about this. The Economic Times cited University of Richmond School of Law professor Carl Tobias' appraisal of Trump's stance on immigration winning over Harris', and mentioned how Trump had increased his support from Hispanics, especially near the Mexican–American border and in areas impacted by recent immigration. Harris campaigning at multiple events with former Republican representative Liz Cheney has been suggested as a contributing factor as to why she lost. Los Angeles Times's Noah Bierman felt Harris could not overcome being the "turn the page" candidate, and cited former president Barack Obama's lead strategist David Axelrod, who said: "If you're the vice president of an administration people want to fire, you're way behind the eight-ball to start." Bierman wrote that besides criminal context, Trump "never followed a script, scoffed at the rules and spoke directly to the economic and cultural anxieties of the country". In The New York Times, Timothy Shenk argued that Democrats failed to articulate a vision for the future other than being against Trump and did not lean into a message of economic populism that polled best with swing voters, but also that the election looked more like a rejection of Biden than the embrace of Trump.
The hysteresis of a hydrogel refers to the phenomenon where there is a delay in the deformation and recovery of a hydrogel when it is subjected to mechanical stress and relieved of that stress. This occurs because the polymer chains within a hydrogel rearrange, and the water molecules are displaced, and energy is stored as it deforms in mechanical extension or compression. When the mechanical stress is removed, the hydrogel begins to recover its original shape, but there may be a delay in the recovery process due to factors like viscoelasticity, internal friction, etc. This leads to a difference between the stress-strain curve during loading and unloading. Hysteresis within a hydrogel is influenced by several factors including composition, crosslink density, polymer chain structure, and temperature. The toughness and hysteresis of a hydrogel are especially important in the context of biomedical applications such as tissue engineering and drug delivery, as the hydrogel may need to withstand mechanical forces within the body, but also maintain mechanical performance and stability over time. Most typical hydrogels, both natural and synthetic, have a positive correlation between toughness and hysteresis, meaning that the higher the toughness, the longer the hydrogel takes to recover its original shape and vice versa. This is largely due to sacrificial bonds being the source of toughness within many of these hydrogels.
Sources: en.wikipedia.org
By the end of the 18th century, Cossack nations had been transformed into a special military estate (sosloviye), "a military class". The Malorussian Cossacks (the former Registered Cossacks also known as "Town Zaporozhian Host") were excluded from this transformation, but were promoted to membership of various civil estates or classes (often Russian nobility), including the newly created civil estate of Cossacks. Under a semi-feudal system retained until the end of the Russian Empire, Cossack families received grants of land which they retained free of taxation, provided that commitments to perform military service were met. Typically a single father or son from each registered family would serve several years full-time with his Host before becoming a reservist liable for recall only in the event of emergency or general mobilisation. When joining his regiment a Cossack was required to bring his own horse, uniform clothing, and basic weaponry (sabres and lances) although the larger and more affluent Hosts might assist in sourcing these essentials. The Russian central government provided only firearms plus food and accommodation. Lacking horses, the poor served in the Cossack infantry and artillery. In the navy alone, Cossacks served with other peoples as the Russian navy had no Cossack ships and units. Cossack service was considered rigorous.
== Gene expression == The gene from which this enzyme is synthesized is mostly expressed in the liver, with some expression in the kidneys, skeletal muscle, and brain. It is also expressed in melanocytes, synovium, placenta, breasts, fetal liver and heart.
===== Efficacy ===== After its launch in 2015 and marketed as Addyi, the drug experienced controversies and rejection from being acknowledged after three reviews on the clinical trials. Regarding the eligible prescription criteria concluded from the trials, the patient should have a diagnosed psychological pathology, medical comorbidities, and the presence of personal relationship issues. Despite being the first drug, its efficacy was not significant for treatment less than at least four weeks. Treatment withdrawal is also practiced if recipients do not experience improvements in symptoms after eight weeks. Nevertheless, around 18% of the gain was observed after 24 weeks of treatment.
== International popularity == Subs or their national equivalents were already popular in many European, Asian, and Australasian countries when late 20th-century franchisee chain restaurants such as Subway and fast food outlets made them even more popular and increased the prevalence of the word sub. Many outlets offer non-traditional ingredient combinations. Major international chains include Firehouse Subs, Quiznos, Mr. Sub, Jersey Mike's, Jimmy John's, Potbelly Sandwich Shop, and the largest restaurant chain in the world, Subway.
Sources: en.wikipedia.org
The sequence corresponds to a fragment of a protein found in human gastric juice, so related sequences are natural. The isolated fifteen-amino-acid peptide supplied for research is produced synthetically. Whether the free fragment circulates naturally in humans has not been settled.
In most jurisdictions it is not an approved medicine and is handled as a research material. Import and sale rules differ by country, and some regulators have placed it in categories that restrict human use. Status can change, so current local rules apply.
Rodent models dominate, particularly rats with induced gastric lesions, tendon injury, or vascular disruption. These designs allow controlled comparison but differ anatomically and metabolically from humans. Results from such models are commonly cited as preliminary.
The letters BPC stand for body protection compound. The number 157 refers to a specific fragment designation from early work on gastric proteins. The full name is a label for a synthetic fifteen-amino-acid peptide rather than a naturally isolated drug.